The CEO of Instant NanoBiosensors, Tony Chung, was recently interviewed by Pharma Boardroom to talk about the potential of the FOPPR technology, the commercialization strategy of the Biomarker Analyzer INB-D200, and the advantages of being a Taiwanese diagnostics device startup!

Interview feature: https://pharmaboardroom.com/interviews/tony-chung-ceo-co-founder-instant-nanobiosensors-taiwan/